/ Press

Get to know us better and help spread the word.

Our purpose is to improve outcomes for everyone by empowering cancer patients and democratizing healthcare. Please contact us with any press requests or inquiries.

Featured Coverage

Outcomes4Me partners with Labcorp and NBCUniversal on cancer care

While it’s impossible to quantify the impact of medical innovation on the world of cancer...

:: MM+M

The Pace of Cancer Innovation Will Lead to Poorer Outcomes, Unless We Empower Patients

In April, we commemorate National Cancer Control Month as well as National Minority Cancer Awareness...

:: HLTH

Health Tech: Maya Said On How Outcomes4Me’s Technology Can Make An Important Impact On Our Overall Wellness

You need to be very, very clear on the compass of your company. What value...

:: Medium

Mission-based cancer care platform Outcomes4Me uses Khoury students to fuel growth

Maya R. Said, Sc.D. put together a lengthy and varied career in the two decades...

:: Futureproof

Revolutionizing Cancer Care and Redefining Patient Empowerment (ft. Sami Shalabi, Outcomes4Me)

Sami is a true visionary in the healthcare technology space, with a background that includes...

:: Springer

Feasibility of introducing a smartphone navigation application into the care of breast cancer patients (The FIONA Study)

Patients with breast cancer (BC) face complex medical information and decisions. The Outcomes4Me mobile app...

:: HLTH

The Pace of Cancer Innovation Will Lead to Poorer Outcomes, Unless We Empower Patients

In April, we commemorate National Cancer Control Month as well as National Minority Cancer Awareness...

Press Releases

Outcomes4Me and CURE® Media Group Partner to Accelerate Patient Access to Innovative Cancer Therapies

Exclusive collaboration empowers patients with cancer through access to evidence-based and informative resources that provide...

December 04, 2024

Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients

Research to be presented in a joint poster session with Labcorp at the 2024 San...

November 26, 2024

Outcomes4Me and the National Comprehensive Cancer Network (NCCN) Expand Collaboration to Improve Outcomes for Patients Diagnosed with Prostate Cancer

Enhanced integration fuels the rapid growth of this first-of-its kind platform and related initiative between...

November 21, 2024

Outcomes4Me Named Finalist in the Health Products Category of Fast Company’s 2024 World Changing Ideas Awards

This distinguished award comes on the heels of several other award wins for Outcomes4Me and...

May 16, 2024

Biovica and Outcomes4Me Partner to Support Metastatic Breast Cancer Patients to Better Understand the Effectiveness of their Treatment

UPPSALA, SE / ACCESS Newswire / March 12, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Today, Biovica, a leader...

March 12, 2025

Michael Sheeley Joins Outcomes4Me as Chief Product Officer

BOSTON–December 16, 2024—Outcomes4Me Inc. announced today that Michael Sheeley has joined the company as Chief...

December 16, 2024

Outcomes4Me and CURE® Media Group Partner to Accelerate Patient Access to Innovative Cancer Therapies

Exclusive collaboration empowers patients with cancer through access to evidence-based and informative resources that provide...

December 04, 2024

Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients

Research to be presented in a joint poster session with Labcorp at the 2024 San...

November 26, 2024

Outcomes4Me and the National Comprehensive Cancer Network (NCCN) Expand Collaboration to Improve Outcomes for Patients Diagnosed with Prostate Cancer

Enhanced integration fuels the rapid growth of this first-of-its kind platform and related initiative between...

November 21, 2024

Outcomes4Me Named Finalist in the Health Products Category of Fast Company’s 2024 World Changing Ideas Awards

This distinguished award comes on the heels of several other award wins for Outcomes4Me and...

May 16, 2024

Biovica and Outcomes4Me Partner to Support Metastatic Breast Cancer Patients to Better Understand the Effectiveness of their Treatment

UPPSALA, SE / ACCESS Newswire / March 12, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Today, Biovica, a leader...

March 12, 2025

Michael Sheeley Joins Outcomes4Me as Chief Product Officer

BOSTON–December 16, 2024—Outcomes4Me Inc. announced today that Michael Sheeley has joined the company as Chief...

December 16, 2024

Outcomes4Me and CURE® Media Group Partner to Accelerate Patient Access to Innovative Cancer Therapies

Exclusive collaboration empowers patients with cancer through access to evidence-based and informative resources that provide...

December 04, 2024

Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients

Research to be presented in a joint poster session with Labcorp at the 2024 San...

November 26, 2024

Get to know us better and help spread the word.

Featured Coverage

Outcomes4Me partners with Labcorp and NBCUniversal on cancer care

The Pace of Cancer Innovation Will Lead to Poorer Outcomes, Unless We Empower Patients

Health Tech: Maya Said On How Outcomes4Me’s Technology Can Make An Important Impact On Our Overall Wellness

In the News

The Beat by BostInno

An Evaluation of Interactive mHealth Applications for Adults Living with Cancer

Breast cancer success: Drug found to reduce risk of cancer coming back

Beyond Women’s History Month: Part 2

Mission-based cancer care platform Outcomes4Me uses Khoury students to fuel growth

Revolutionizing Cancer Care and Redefining Patient Empowerment (ft. Sami Shalabi, Outcomes4Me)

Feasibility of introducing a smartphone navigation application into the care of breast cancer patients (The FIONA Study)

The Pace of Cancer Innovation Will Lead to Poorer Outcomes, Unless We Empower Patients

Press Releases

If you’re a member of the press, please reach out.

If you’re a member of the press,
please reach out.